Clinical Trial

Apnea of Prematurity Results in Respiratory Distress and Cyanosis. Caffeine Citrate Can Treat It.

Study acronym: AOP
Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated April 1, 2025 (before its estimated December 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
High-dose caffeine citrate is more effective than low-dose caffeine citrate in the treatment of apnea of prematurity (AOP). The high-dose group showed fewer apnea episodes, higher extubation success rate, lower extubation failure rate and shorter duration of oxygen therapy
Trial Details
NCT Number NCT06905496
Lead Sponsor Nishtar Medical University
Conditions Apnea of Prematurity
Enrollment 114 participants
Start Date 2024-06-03
Primary Completion 2025-12-01 (estimated)
Study Completion 2026-03-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-01